Permeasis
Boston, US · 1 known investors
Permeasis Therapeutics is developing a Membrane Translocation Domain (MTD) platform that enables intracellular delivery of proteins and other large therapeutic macromolecules to the cytosol and intracellular compartments. The company initially targets genetically defined diseases where delivering functional proteins inside cells could have therapeutic impact.
Investors · 1
Frequently asked questions
- What does Permeasis do?
- Permeasis Therapeutics is developing a Membrane Translocation Domain (MTD) platform that enables intracellular delivery of proteins and other large therapeutic macromolecules to the cytosol and intracellular compartments. The company initially targets genetically defined diseases where delivering functional proteins inside cells could have therapeutic impact.
- Who are Permeasis's investors?
- Permeasis's investors include Cure Ventures.
- Where is Permeasis headquartered?
- Permeasis is headquartered in Boston, US.